default author photo

Nino Lomtadze

National Center for Tuberculosis and Lung Diseases

SCHOLARLY PAPERS

2

DOWNLOADS

257

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Cost-Effectiveness of Modified Fully Oral Nine-Month Treatment Regimens for Rifampicin-Resistant Tuberculosis in Belarus, Georgia, Kazakhstan and Republic of Moldova

Number of pages: 22 Posted: 02 Jul 2024
University College London, University College London - Institute for Global Health, UCL Institute for Global Health, World Health Organization (WHO) - World Health Organization Regional Office for Europe, World Health Organization (WHO) - World Health Organization Regional Office for Europe, Chiril Draganiuc Institute of Phthisiopneumology, University College London, University College London, University College London, Chiril Draganiuc Institute of Phthisiopneumology, National Scientific Center of Phthisiopulmonology, National Scientific Center of Phthisiopulmonology, National Scientific Center of Phthisiopulmonology, National Scientific Center of Phthisiopulmonology, National Scientific Center of Phthisiopulmonology, , Minsk Republican Scientific and Practical Centre of Pulmonology and Tuberculosis, Minsk Republican Scientific and Practical Centre of Pulmonology and Tuberculosis, National Center for Tuberculosis and Lung Diseases, National Center for Tuberculosis and Lung Diseases, National Center for Tuberculosis and Lung Diseases, National Center for Tuberculosis and Lung Diseases, National Center for Tuberculosis and Lung Diseases, National Center for Disease Control and Public Health, National Center for Disease Control and Public Health, The Global Fund to Fight AIDS, Tuberculosis and Malaria, University College London - Institute for Global Health and University College London - Institute for Global Health
Downloads 141 (521,245)

Abstract:

Loading...

Multidrug-resistance, Tuberculosis, Europe, Bedaquiline, Modified short treatment regimen, Rifampicin-resistance

2.

Effectiveness and Safety of Modified Fully Oral Nine-Month Treatment Regimens for Rifampicin-Resistant Tuberculosis: Prospective Cohort Study

Number of pages: 26 Posted: 20 Feb 2024
World Health Organization (WHO) - World Health Organization Regional Office for Europe, Karolinska Institutet, University of Tartu, World Health Organization (WHO) - World Health Organization Regional Office for Europe, National Center for Tuberculosis and Lung Diseases, World Health Organization (WHO) - World Health Organization Regional Office for Europe, Minsk Republican Scientific and Practical Centre of Pulmonology and Tuberculosis, PATH, Riga East University Hospital, Harvard University - Division of Global Health Equity, Government of the Republic of Armenia - Ministry of Health, Republic of Armenia, World Health Organization (WHO) - World Health Organization Regional Office for Europe, Ministry of Health, Kyrgyzstan, Ministry of Health of Ukraine, Scientific Research Institute of Lung Diseases, National Scientific Center of Phthisiopulmonology, Turkmen State Medical University, National Center for Tuberculosis and Lung Diseases, , National Tuberculosis Treatment and Prevention Center, Ministry of Health and Social Protection of the Population, Tajikistan, Klaipeda University, Chiril Draganiuc Institute of Phthisiopneumology, Istituti Clinici Scientifici Maugeri IRCCS - Servizio di Epidemiologia Clinica delle Malattie Respiratorie, World Health Organization (WHO) - World Health Organization Regional Office for Europe and World Health Organization (WHO) - World Health Organization Regional Office for Europe
Downloads 116 (613,149)
Citation 1

Abstract:

Loading...

Tuberculosis, drug-resistance, treatment effectivness, operational research, shorter regimens